Catalyst Wire Dossier Catalyst Wire Dossier

Pergoveris

follitropin alfa and lutropin alfa · Merck KGaA
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Pergoveris, covering 2014-02-24 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin [Phase 1]

See pricing